NYSE
According to Zyberno, MARCUS CORP (MCS) is not a buy — WEAK BUSINESS (39/100) with a negative Margin of Safety of -100.0% and a Brina Gap of -17.4% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, MARCUS CORP (MCS) trades at $29.02 against an estimated intrinsic value per share of $11.60 — a -100.0% Margin of Safety based on Owner Earnings of $46.00M TTM, projected at -9.0% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -17.4% weakens the case: based on the company's ROIC (3.6%) and reinvestment rate (61.1%), the business can fundamentally grow at 2.2% — but the current enterprise value implies the market expects 19.6%. This places MCS in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -24.6% annually.
Over the trailing twelve months, MCS generated $46.00M in Owner Earnings. Capital was deployed as follows: $9.39M paid as dividends, $66.85M invested in capital expenditures. Reinvestment rate: 61.1%. Owner Earnings have declined at 9.0% annually over the trailing five years using log-linear regression.